These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7830031)

  • 1. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies.
    Tall AR
    J Intern Med; 1995 Jan; 237(1):5-12. PubMed ID: 7830031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A; Brown ML; Hesler CB; Agellon LB; Koizumi J; Takata K; Maruhama Y; Mabuchi H; Tall AR
    N Engl J Med; 1990 Nov; 323(18):1234-8. PubMed ID: 2215607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.
    Masucci-Magoulas L; Moulin P; Jiang XC; Richardson H; Walsh A; Breslow JL; Tall A
    J Clin Invest; 1995 Apr; 95(4):1587-94. PubMed ID: 7706465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.
    Francone OL; Royer L; Haghpassand M
    J Lipid Res; 1996 Jun; 37(6):1268-77. PubMed ID: 8808761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human HDL apolipoproteins. Lack of lipid transfer inhibitory activity in transgenic mice expressing human apoA-I.
    Masson D; Duverger N; Emmanuel F; Lagrost L
    J Biol Chem; 1997 Sep; 272(39):24287-93. PubMed ID: 9305883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.
    Masson D; Pais de Barros JP; Zak Z; Gautier T; Le Guern N; Assem M; Chisholm JW; Paterniti JR; Lagrost L
    J Lipid Res; 2006 Feb; 47(2):356-65. PubMed ID: 16282639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.
    Melchior GW; Castle CK; Murray RW; Blake WL; Dinh DM; Marotti KR
    J Biol Chem; 1994 Mar; 269(11):8044-51. PubMed ID: 8132527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport.
    Bruce C; Chouinard RA; Tall AR
    Annu Rev Nutr; 1998; 18():297-330. PubMed ID: 9706227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
    Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
    Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cholesteryl ester transfer protein inhibitor from plasma of baboons (Papio sp.).
    Kushwaha RS; Hasan SQ; McGill HC; Getz GS; Dunham RG; Kanda P
    J Lipid Res; 1993 Aug; 34(8):1285-97. PubMed ID: 8409763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.
    Nagano M; Yamashita S; Hirano K; Takano M; Maruyama T; Ishihara M; Sagehashi Y; Kujiraoka T; Tanaka K; Hattori H; Sakai N; Nakajima N; Egashira T; Matsuzawa Y
    J Atheroscler Thromb; 2004; 11(3):110-21. PubMed ID: 15256762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein: an enigmatic protein.
    Moulin P
    Horm Res; 1996; 45(3-5):238-44. PubMed ID: 8964591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased atherosclerosis in ApoE and LDL receptor gene knock-out mice as a result of human cholesteryl ester transfer protein transgene expression.
    Plump AS; Masucci-Magoulas L; Bruce C; Bisgaier CL; Breslow JL; Tall AR
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1105-10. PubMed ID: 10195942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency.
    Oliveira HC; Ma L; Milne R; Marcovina SM; Inazu A; Mabuchi H; Tall AR
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1045-52. PubMed ID: 9194753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.
    Takahashi K; Jiang XC; Sakai N; Yamashita S; Hirano K; Bujo H; Yamazaki H; Kusunoki J; Miura T; Kussie P
    J Clin Invest; 1993 Oct; 92(4):2060-4. PubMed ID: 8408659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice.
    Gautier T; Masson D; Jong MC; Duverneuil L; Le Guern N; Deckert V; Pais de Barros JP; Dumont L; Bataille A; Zak Z; Jiang XC; Tall AR; Havekes LM; Lagrost L
    J Biol Chem; 2002 Aug; 277(35):31354-63. PubMed ID: 12070157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing of the human cholesteryl ester transfer protein gene in transgenic mice. Exon exclusion modulates gene expression in response to dietary or developmental change.
    Yang TP; Agellon LB; Walsh A; Breslow JL; Tall AR
    J Biol Chem; 1996 May; 271(21):12603-9. PubMed ID: 8647871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
    Hirano K; Yamashita S; Nakajima N; Arai T; Maruyama T; Yoshida Y; Ishigami M; Sakai N; Kameda-Takemura K; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1053-9. PubMed ID: 9194754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.